This shot could up your cardiac risk… by 700%!
The FDA is about to make what will probably be one of its worst decisions ever regarding the approval of a vaccine.
It’s one that will be shoved down the throats of anyone over 18 for the purpose of preventing hepatitis B.
But what it very well may end up doing is causing an epidemic of heart attacks.
How in the world, you might ask, could our so-called “watchdog” agency be poised to put so many citizens at such a big risk?
That would be an excellent question… a question that the FDA is hoping to dodge anyway it can.
Twisting the facts
“There is a simple rule in life,” says cardiologist Milton Packer. “If you don’t know, you should say that you don’t know.”
But try telling that to biotech company Dynavax. The drugmaker is doing its best to confuse the issue over the fact that its vaccine for hep B, dubbed Heplisav, was found to up the risk of suffering a heart attack by 700 percent!
No, that’s not a typo.
So, how did the drugmaker respond to that?
Dynavax released a statement saying that its vaccine didn’t really cause more heart attacks. The problem was that the people who took the other shot it was being tested against had fewer heart attacks.
What? That’s like telling a police officer that you weren’t speeding, the other cars were just going too slow!
Despite those frightening findings, however, an FDA advisory panel just voted 12 to 1, saying the agency should go ahead and approve Heplisav. Three members abstained from voting, with Dr. Packer being one of them.
The FDA said it will make its decision before the year is over. And I think it’s pretty much a shoo-in that this new shot will land in your doctor’s office before Christmas rolls around.
But what is it that makes this vaccine so incredibly dangerous?
Dr. Packer brought up the possibility of the new “adjuvant” being used in the shot causing “an inflammatory response” of unknown duration. And that’s a very likely possibility.
Inflammation is well known to cause the rupture of plaque in your arteries. When that happens, a sudden blood clot can form, triggering a heart attack or stroke.
And adjuvants aren’t just some inactive ingredient used in vaccines for no reason at all. They’re potent chemicals drugmakers add to shots to jumpstart your immune reaction.
And the contents of this particular one, called 1018, are a deep, dark secret. Or, as it’s called in Big Pharma lingo — “proprietary.”
What we do know about 1018 is that even the vaccine-happy FDA has been hemming and hawing over it since 2012, when Dynavax first submitted the application for this shot to the agency.
If you’ve had a baby or a grandchild born within the past two decades, you might know that this rush to vaccinate against hep B starts almost immediately after a baby is born. It’s unbelievable.
There are already several other brands of a hep B vaccine on the market, with the first shot given to infants minutes after birth, then at least two more times before they even start kindergarten!
And just because Heplisav was shown so dramatically to up heart-attack risk doesn’t mean that any and all other vaccinations, from shingles to polio to the flu shot, don’t trigger the very same danger.
That’s because practically every shot out there has never been specifically tested to see if it will raise your risk of a heart attack or stroke.
What turned up with Heplisav was just so dramatic that it couldn’t be ignored.
Soon, Heplisav will hit the market, and untold numbers of Americans will become the guinea pigs for its “post-marketing” trial, and then the real-world effects of this drug will come to light.
No doubt, that’s when FDA officials will shake their heads and say “Who knew?”
“Does a new hepatitis vaccine cause heart attacks?” Milton Packer, August 2, 2017, Medpage Today, medpagetoday.com
